Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 11, 2009
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
O L Lopez, J T Becker, A S Wahed, et al.
Translational Psychiatry
|
June 3, 2015
Genome-wide copy-number variation study of psychosis in Alzheimer's disease
X Zheng, F Y Demirci, M M Barmada, et al.
Biological Psychiatry
|
December 5, 1997
Association of plasma homovanillic acid with behavioral symptoms in patients diagnosed with dementia: a preliminary report
R A Sweet, B G Pollock, B H Mulsant, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 13, 2023
Differential regulation of MAP2 by phosphorylation events in proline-rich versus C-terminal domains
R A DeGiosio, P G Needham, O A Andrews, et al.
Archives of Neurology
|
March 20, 2001
Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis
R A Sweet, R L Hamilton, M T Healy, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
July 26, 2000
Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients
D C Mamo, R A Sweet, B H Mulsant, et al.
International Psychogeriatrics
|
March 27, 2001
Psychotic symptoms in Alzheimer's disease are not associated with more severe neuropathologic features
R A Sweet, R L Hamilton, O L Lopez, et al.
The Journal of Clinical Psychiatry
|
September 20, 2001
A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life
B H Mulsant, R A Sweet, J Rosen, et al.
The Journal of Clinical Psychiatry
|
May 1, 1995
Monoamine oxidase inhibitor dietary restrictions: what are we asking patients to give up?
R A Sweet, E J Brown, R G Heimberg, et al.
Biorxiv : the Preprint Server for Biology
|
December 12, 2025
Proteomic Analysis in Alzheimer's Disease with Psychosis Reveals Separate Molecular Signatures for Core AD Proteinopathy and Postsynaptic Density Disruption
T S Ku, S J Mullett, Z Sui, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 11, 2009
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
O L Lopez, J T Becker, A S Wahed, et al.
Translational Psychiatry
|
June 3, 2015
Genome-wide copy-number variation study of psychosis in Alzheimer's disease
X Zheng, F Y Demirci, M M Barmada, et al.
Biological Psychiatry
|
December 5, 1997
Association of plasma homovanillic acid with behavioral symptoms in patients diagnosed with dementia: a preliminary report
R A Sweet, B G Pollock, B H Mulsant, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 13, 2023
Differential regulation of MAP2 by phosphorylation events in proline-rich versus C-terminal domains
R A DeGiosio, P G Needham, O A Andrews, et al.
Archives of Neurology
|
March 20, 2001
Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis
R A Sweet, R L Hamilton, M T Healy, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
July 26, 2000
Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients
D C Mamo, R A Sweet, B H Mulsant, et al.
International Psychogeriatrics
|
March 27, 2001
Psychotic symptoms in Alzheimer's disease are not associated with more severe neuropathologic features
R A Sweet, R L Hamilton, O L Lopez, et al.
The Journal of Clinical Psychiatry
|
September 20, 2001
A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life
B H Mulsant, R A Sweet, J Rosen, et al.
The Journal of Clinical Psychiatry
|
May 1, 1995
Monoamine oxidase inhibitor dietary restrictions: what are we asking patients to give up?
R A Sweet, E J Brown, R G Heimberg, et al.
Biorxiv : the Preprint Server for Biology
|
December 12, 2025
Proteomic Analysis in Alzheimer's Disease with Psychosis Reveals Separate Molecular Signatures for Core AD Proteinopathy and Postsynaptic Density Disruption
T S Ku, S J Mullett, Z Sui, et al.
Page
of 8